Gerald Friedland, MD

Professor Emeritus of and Senior Research Scientist in Medicine (Infectious Diseases); Professor Emeritus of Medicine and Epidemiology and Public Health; Senior Research Scientist, Infectious Diseases

Research Departments & Organizations

School of Public Health: Center for Interdisciplinary Research on AIDS | Epidemiology of Microbial Diseases

Internal Medicine: CPIRT - Pulmonary Infection Research and Treatment | Infectious Diseases: Clinical & Community Research (YCCR)

Yale Institute for Global Health

Global Health Studies

MacMillan Center

Office of Cooperative Research

Research Interests

Acquired Immunodeficiency Syndrome; Africa, Southern; Anti-Retroviral Agents; Epidemiology; Extensively Drug-Resistant Tuberculosis; Geographicals; Global Health; HIV; Infectious Disease Medicine; Public Health; Tuberculosis

Research Summary

Dr. Friedland's major research interests are in the provision of HIV care to vulnerable populations and clinical trials of anti-retroviral agents, including adherence to HIV therapies and pharmacologic interaction studies between methadone and buprenorphine and antiretroviral agents. Dr. Friedland is also involved in studies of HIV and risk reduction among HIV seropositives in clinical care and, most recently, in studies on the integration of care and treatment of tuberculosis and HIV disease in resource limited settings, notably South Africa. His group has uncovered the epidemic of XDR TB in South Africa and is working on epidemiologic, clinical and mycobacteriologic studies in this area.

Specialized Terms: HIV care; Injection drug use and HIV; Anti-retroviral agents; Tuberculosis, HIV and TB; drug resistant TB; Prevention and treatment in vulnerable populations

Extensive Research Description

Gerald Friedland is a professor of medicine, epidemiology and public health at the Yale School of Medicine and the Yale School of Public Health. He is active in the provision of clinical care and in clinical and epidemiologic research of HIV/AIDS. Dr. Friedland's research interests lie at the interface of HIV biology, clinical care and behavior, and he directs large-scale clinical and epidemiologic studies among vulnerable populations with and at risk for HIV. Dr. Friedland also investigates how to integrate HIV and tuberculosis care in resource-limited settings, with a focus on South Africa. He also develops programs to educate health care providers in HIV care and studies transmission of antiretroviral resistance.

Dr. Friedland received his M.D. from New York University School of Medicine. He is the director of the AIDS program at Yale-New Haven Hospital and serves on the World Health Organization HIV/TB working group. He is a former member of the governing council of the International AIDS Society and was editor-in-chief of Journal Watch HIV/AIDS Clinical Care. He also serves as the chairman of the board of directors of the Aaron Diamond AIDS Research Center and is a trustee of the HIV Research Trust. He is a visiting professor at the Nelson R. Mandela School of Medicine of the University of KwaZulu-Natal in Durban, South Africa.

Clinical Trials

Conditions Study Title
HIV/AIDS, Infectious Diseases Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
HIV/AIDS, Infectious Diseases Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (REPRIEVE)


  • TB, HIV, South Africa Tugela Ferry, South Africa (2002)

    Integrating HIV and TB diagnosis, care and treatment
    Confronting XDR TB and HIV in Rural South Africa

Selected Publications

See list of PubMed publications

Edit this profile

Contact Info

Gerald Friedland, MD
Office Location
135 College Street, Ste 323
New Haven, CT 06510
Mailing Address
135 College St
New Haven, CT 06510

Curriculum Vitae